I. Introduction
OSA is a form of respiratory dysfunction affecting 20% of adults worldwide [1] and is caused by a collapse of the soft tissue surrounding the upper airway, thereby obstructing airflow during sleep. To prevent asphyxiation, the patient arouses to increase respiratory effort by shifting from a deeper to a lighter stage of sleep. These cycles of collapse- obstruction-arousal can happen hundreds of times over the course of a single night and have multiple long-term negative effects on the patient's health. Patients are at an increased risk of cardiovascular, cerebrovascular and metabolic syndromes such as hypertension, stroke and diabetes [2]. Many patients experience excessive daytime sleepiness and impaired cognitive function. If untreated, the average life span of a patient with obstructive sleep apnea has been estimated to be 20 years shorter than the average life span of the general population [3]. However, with proper diagnosis and treatment, many of these risks can be reduced to give the patient more fulfilling wakening hours and overall better health.